1. Home
  2. MTAL vs TNDM Comparison

MTAL vs TNDM Comparison

Compare MTAL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTAL
  • TNDM
  • Stock Information
  • Founded
  • MTAL 2021
  • TNDM 2006
  • Country
  • MTAL Jersey
  • TNDM United States
  • Employees
  • MTAL N/A
  • TNDM N/A
  • Industry
  • MTAL Blank Checks
  • TNDM Medical/Dental Instruments
  • Sector
  • MTAL Finance
  • TNDM Health Care
  • Exchange
  • MTAL Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • MTAL 997.3M
  • TNDM 1.1B
  • IPO Year
  • MTAL 2021
  • TNDM 2013
  • Fundamental
  • Price
  • MTAL $12.05
  • TNDM $15.59
  • Analyst Decision
  • MTAL Hold
  • TNDM Buy
  • Analyst Count
  • MTAL 4
  • TNDM 13
  • Target Price
  • MTAL $12.08
  • TNDM $32.15
  • AVG Volume (30 Days)
  • MTAL 757.6K
  • TNDM 1.6M
  • Earning Date
  • MTAL 08-09-2025
  • TNDM 08-06-2025
  • Dividend Yield
  • MTAL N/A
  • TNDM N/A
  • EPS Growth
  • MTAL N/A
  • TNDM N/A
  • EPS
  • MTAL N/A
  • TNDM N/A
  • Revenue
  • MTAL $340,736,000.00
  • TNDM $982,951,000.00
  • Revenue This Year
  • MTAL $18.41
  • TNDM $8.91
  • Revenue Next Year
  • MTAL $23.55
  • TNDM $11.04
  • P/E Ratio
  • MTAL N/A
  • TNDM N/A
  • Revenue Growth
  • MTAL 114.30
  • TNDM 27.65
  • 52 Week Low
  • MTAL $7.69
  • TNDM $15.17
  • 52 Week High
  • MTAL $14.93
  • TNDM $48.24
  • Technical
  • Relative Strength Index (RSI)
  • MTAL 60.65
  • TNDM 27.20
  • Support Level
  • MTAL $11.94
  • TNDM $15.17
  • Resistance Level
  • MTAL $12.09
  • TNDM $17.12
  • Average True Range (ATR)
  • MTAL 0.09
  • TNDM 0.99
  • MACD
  • MTAL -0.07
  • TNDM -0.31
  • Stochastic Oscillator
  • MTAL 50.00
  • TNDM 6.99

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: